retatrutide approval status 2025 retatrutide fda approval Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam retatrutide approval status october 2025

Orforglipron does not require fasting or other dosing restrictions, which may offer a meaningful practical advantage for patients

Retinoids have plenty of clinical backing for skin appearance, but that adjustment period takes a toll: dryness, flaking, redness, heightened sun sensitivity

Initiating GLP-1 therapy requires careful preparation and realistic expectations

Patients control whether they opt into any partner-related opportunities and can request that their account and data be deleted at any time

Aside from weight loss, if you wish to increase muscle size, taking creatine can be beneficial

Your clinician will give you instructions on the exact timing of use